Literature DB >> 10082433

HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).

F K Tan1, D N Stivers, F C Arnett, R Chakraborty, R Howard, J D Reveille.   

Abstract

Choctaw Native Americans in southeastern Oklahoma have the highest prevalence of scleroderma or systemic sclerosis yet found (469/100,000). An Amerindian HLA DR2 haplotype (DRB1*1602) was significantly associated with scleroderma in this population in a previous study. It is not known, however, if other disease genes are linked to this HLA haplotype. The regions flanking the HLA loci were studied with polymorphic microsatellite markers. An extended HLA DR2 (DRB1*1602, DQA1*0501, DQB1*0301, DPB1*1301) haplotype that includes the class I and III regions was identified which was significantly associated with scleroderma in the Oklahoma Choctaw. No other significant associations with microsatellite marker alleles immediately flanking the HLA region were found.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082433     DOI: 10.1034/j.1399-0039.1999.530108.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

Review 1.  The genetics of systemic sclerosis.

Authors:  Randall W Johnson; Monty B Tew; Frank C Arnett
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Tests for the homogeneity of two binomial proportions in extremely unbalanced 2 x 2 contingency tables.

Authors:  Seung-Ho Kang; Chul W Ahn
Journal:  Stat Med       Date:  2008-06-30       Impact factor: 2.373

Review 3.  Geoepidemiology of autoimmune rheumatic diseases.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2010-06-22       Impact factor: 20.543

4.  Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.

Authors:  Pravitt Gourh; Sandeep K Agarwal; Dipal Divecha; Shervin Assassi; Gene Paz; Rajpreet K Arora-Singh; John D Reveille; Sanjay Shete; Maureen D Mayes; Frank C Arnett; Filemon K Tan
Journal:  Arthritis Rheum       Date:  2009-12

Review 5.  Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?

Authors:  Nedim Durmus; Sung-Hyun Park; Joan Reibman; Gabriele Grunig
Journal:  Curr Opin Rheumatol       Date:  2016-11       Impact factor: 5.006

6.  Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.

Authors:  Pravitt Gourh; Sandeep K Agarwal; Ezequiel Martin; Dipal Divecha; Blanca Rueda; Haley Bunting; Shervin Assassi; Gene Paz; Sanjay Shete; Terry McNearney; Hilda Draeger; John D Reveille; T R D J Radstake; Carmen P Simeon; Luis Rodriguez; Esther Vicente; Miguel A Gonzalez-Gay; Maureen D Mayes; Filemon K Tan; Javier Martin; Frank C Arnett
Journal:  J Autoimmun       Date:  2009-09-30       Impact factor: 7.094

Review 7.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 8.  Epidemiology of organic solvents and connective tissue disease.

Authors:  D H Garabrant; C Dumas
Journal:  Arthritis Res       Date:  1999-12-01

9.  HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.

Authors:  Pravitt Gourh; Sarah A Safran; Theresa Alexander; Steven E Boyden; Nadia D Morgan; Ami A Shah; Maureen D Mayes; Ayo Doumatey; Amy R Bentley; Daniel Shriner; Robyn T Domsic; Thomas A Medsger; Paula S Ramos; Richard M Silver; Virginia D Steen; John Varga; Vivien Hsu; Lesley Ann Saketkoo; Elena Schiopu; Dinesh Khanna; Jessica K Gordon; Brynn Kron; Lindsey A Criswell; Heather Gladue; Chris T Derk; Elana J Bernstein; S Louis Bridges; Victoria K Shanmugam; Kathleen D Kolstad; Lorinda Chung; Suzanne Kafaja; Reem Jan; Marcin Trojanowski; Avram Goldberg; Benjamin D Korman; Peter J Steinbach; Settara C Chandrasekharappa; James C Mullikin; Adebowale Adeyemo; Charles Rotimi; Fredrick M Wigley; Daniel L Kastner; Francesco Boin; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

10.  HLA markers for poor prognosis in systemic sclerosis Brazilian patients.

Authors:  Ana Paula Toledo Del Rio; Zoraida Sachetto; Percival Degrava Sampaio-Barros; João Francisco Marques-Neto; Ana Carolina Santos Londe; Manoel Barros Bertolo
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.